2 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
Follow FutureChem: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2 [177Lu]Ludotadipep - Metastatic Castration-resistant Prostate Cancer, mCRPC | Phase 2 | Unknown | FutureChem | 20 | 2022-10-30 | 2024-04-29 |
| [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application [177Lu]Ludotadipep 3.7 GBq - Metastatic Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | Unknown | FutureChem | 26 | 2022-09-01 | 2024-04-29 |
South Korea (1) · United States (1)
Arif Hussain, MD (1) · Ji Youl Lee, Ph.D (1)